Snowdon, Inc. logo — Dedicated to alleviating pain, combating neurological disord...

Snowdon, Inc.

Dedicated to alleviating pain, combating neurological disorders, and fighting infectious diseases with innovative medicine.

Founded 2005 2 employees Series Unknown Total: $500.00K Pharmaceutical

General Information

Company Name Snowdon, Inc.
Founded Year 2005
Employees 2
Industries Pharmaceutical
Funding Stage Series Unknown
Social

Get notified when Snowdon, Inc. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Snowdon, Inc.

Snowdon, Inc. is a pharmaceutical company committed to addressing the pressing medical needs of sufferers of acute and chronic pain, neurological disorders, and infectious diseases. Founded in 2005, the company aims to introduce innovative and effective treatments in these pivotal therapeutic areas, which impose considerable suffering, economic burden, and loss of life on millions. Snowdon's product pipeline encompasses new chemical entities (NCEs) and the repurposing of off-patent drugs for novel clinical applications. The preclinical lead compound, SND-121, has displayed remarkable safety and efficacy in addressing neuropathic pain in rodent models when administered orally. Notably, $500.00K in funding was secured through a Venture Round investment on 22 March 2007, with Foundation Venture Capital Group participating as the investor. Snowdon's dedication to alleviating pain, combatting neurological disorders, and fighting infectious diseases with innovative medicine positions it as a compelling venture for potential investors in the pharmaceutical sector.

Taxonomy: pharmaceuticals, drug development, pain management, neurology, infectious diseases, therapeutic areas, preclinical research, drug candidates, NCEs, repurposing drugs, neuropathic pain, mechanism of action, market potential, clinical indications

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• 1
Investor
22 Mar 2007

Snowdon, Inc. Alternatives & Competitors

Snowdon, Inc. vs
Epsom-It, Inc.
Epsom-It, Inc. United States

Epsom-It is a unique, patent-pending, natural lotion of super-concentrated pure Epsom Salt for nerve...

Non Equity Assistance
1 employees
Health Care, Wellness Beauty
Snowdon, Inc. vs
Akelos Inc
Akelos Inc United States

Developing Opioid Alternatives for Treating Neuropathic Pain. Now Recruiting Accredited Investors -...

Grant
5 employees
Biopharma, Biotechnology
Snowdon, Inc. vs

Non-opioid drugs for chronic pain to attack a global health epidemic.

Seed
1 employees
Biopharma, Biotechnology

FAQ About Snowdon, Inc.

Dedicated to alleviating pain, combating neurological disorders, and fighting infectious diseases with innovative medicine.
Snowdon, Inc. was founded in 2005.
Snowdon, Inc. operates in the following industries: Pharmaceutical.
Snowdon, Inc. has approximately 2 employees.
Snowdon, Inc. has completed 1 funding round, raising a total of $500.00K. The latest funding stage is Series Unknown.
Top alternatives and competitors to Snowdon, Inc. include Epsom-It, Inc., Akelos Inc, Regulonix Holding, Inc., Pain Physicians NY, PainCeptor. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Snowdon, Inc. and Epsom-It, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Snowdon, Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes